Loading contract…
BETAThis is a new independent transparency project, not an official government website. The data is sourced from public registers and may contain errors, so always verify against the official source. If you find a problem, please report it here.
BCUHB Pathology, as part of the DSCSS directorate, are seeking to appoint an experienced primary Managed Service Contract provider to deliver bespoke In Vitro Diagnostics support for Transfusion services.
BCUHB delivers Transfusion services for Group and Antibody screens, Cross matching, and issuing of products (via remote and electronic issue) across all 3 acute sites (Ysbyty Wrexham Maelor, Ysbyty Glan Clwyd and Ysbyty Gwynedd), with blood stocks provided on a remote/electronic issue basis to satellite services in Abergele, Denbigh, and Llandudno hospitals. The service is registered as compliant with MHRA, and shares a single unified UKAS accreditation across all 3 locations. Each acute site has a fully capable Transfusion laboratory area as part of the Blood Science laboratory and operates on a 24/7 basis as an established and resilient service model. Each site also supports theatres, cancer centres and renal units with the relevant specialist requirements.
No supplier information available.
This procurement was divided into 1 lots, each awarded separately.
| Lot | Value | Status |
|---|---|---|
| Lot 1 Dec 2027 – Nov 2035 | £6,393,516 | active |
Weightings from the notice.